EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Posttreatment Monitoring of Pulmonary Arteriovenous Malformations

Kalei Hering, Patrick Sutphin, Sanjeeva Kalva

CHEST · 2025

DOI: 10.1016/j.chest.2025.06.014 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CHEST, 2025. Verfasst von Kalei Hering und 2 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, MA. Electronic address: kalei_hering@hms.harvard.edu. Hauptthemen laut MEDLINE: Pulmonary Artery, Embolization, Therapeutic, Pulmonary Veins, Arteriovenous Malformations. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TOPIC IMPORTANCE: Pulmonary arteriovenous malformations (PAVMs) require therapeutic embolization and careful surveillance to prevent serious complications, including stroke, brain abscess, and hemoptysis. Although initial treatment guidelines are well established, posttreatment surveillance practices remain heterogeneous, with no standardized approach for monitoring treated lesions or detecting PAVM persistence. This variability in follow-up care may affect patient outcomes, particularly in high-risk populations such as those with hereditary hemorrhagic telangiectasia (HHT). REVIEW FINDINGS: Post-embolization PAVM persistence occurs in up to 25% of treated cases through mechanisms that include recanalization and reperfusion., Current follow-up relies primarily on CT imaging, although radiation exposure remains a concern with repeated studies. Transthoracic contrast echocardiography shows promise for surveillance but requires validation against CT findings. Time-resolved magnetic resonance angiography exhibits 89% sensitivity and 95% specificity for detecting PAVM patency compared with 82% and 81% for CT images, respectively. The newly established multicenter PAVM registry may help standardize surveillance protocols and improve outcome tracking. Special consideration is needed for monitoring during high-risk periods such as pregnancy and adolescence when growth rates may accelerate. SUMMARY: Long-term surveillance is essential following PAVM embolization, particularly in patients with HHT. Although multiple imaging modalities are available, optimal surveillance protocols balancing detection sensitivity with radiation exposure remain undefined. Implementation of standardized follow-up guidelines through multicenter collaboration and registry data may improve risk detection and allow for more timely intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary ArteryEmbolization, TherapeuticPulmonary VeinsArteriovenous MalformationsArteriovenous FistulaHumansTelangiectasia, Hereditary HemorrhagicTomography, X-Ray ComputedMagnetic Resonance AngiographyEchocardiography

Stichwörter der Autor:innen

clinical guidelineshereditary hemorrhagic telangiectasiainterventional radiologymanagement strategiesposttreatment surveillancepulmonary arteriovenous malformationsscreening protocolsvascular malformations

Autor:innen und Institutionen

  • Harvard Medical School, Boston, MA. Electronic address: kalei_hering@hms.harvard.edu.
  • Division of Interventional Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Division of Interventional Radiology, Department of Radiology, University of Texas Southwestern, Dallas, TX.

Zitieren

APA

Hering, K., Sutphin, P., & Kalva, S. (2025). Posttreatment Monitoring of Pulmonary Arteriovenous Malformations. CHEST. https://doi.org/10.1016/j.chest.2025.06.014

Vancouver

Hering K, Sutphin P, Kalva S. Posttreatment Monitoring of Pulmonary Arteriovenous Malformations. CHEST. 2025. doi:10.1016/j.chest.2025.06.014

BibTeX
@article{Hering2025,
  author = {Hering, Kalei and Sutphin, Patrick and Kalva, Sanjeeva},
  title = {Posttreatment Monitoring of Pulmonary Arteriovenous Malformations},
  journal = {CHEST},
  year = {2025},
  doi = {10.1016/j.chest.2025.06.014}
}
Kostenlos starten →